US equities |
GOOGL $283.82 ▼-12.64% GOOG $282.32 ▼-12.29% MSFT $530.14 ▼-0.16% MU $934.27 ▼-4.98% AMZN $243.79 ▼-4.25% META $624.52 ▲+1.96% NVDA $213.66 ▼-0.80% AAPL $348.91 ▲+1.48%
FinancialContent

Liquidia Corporation - Common Stock (NQ:LQDA)

44.99 -0.73 (-1.60%)
Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Liquidia Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Breaking Down Liquidia: 4 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
FDA sets PDUFA goal date of May 24, 2025 
From Liquidia Corporation
Via GlobeNewswire
News headline image
Breaking Down Liquidia: 4 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025
From Liquidia Corporation
Via GlobeNewswire
News headline image
The Analyst Landscape: 11 Takes On Liquidia ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2024 ↗
 
Via Benzinga
News headline image
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
What 4 Analyst Ratings Have To Say About Liquidia ↗
 
Via Benzinga
News headline image
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
News headline image
Uncovering Potential: Liquidia's Earnings Preview ↗
 
Via Benzinga
News headline image
Evaluating Liquidia: Insights From 14 Financial Analysts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 19, 2025 ↗
 
Via Benzinga
News headline image
Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025
From Liquidia Corporation
Via GlobeNewswire
News headline image
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
From Atea Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia to Present at the Stifel 2024 Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
From Liquidia Corporation
Via GlobeNewswire
News headline image
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
From Liquidia Corporation
Via GlobeNewswire
News headline image
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
From Liquidia Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >